Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:vaccine
|
| gptkbp:bfsLayer |
4
|
| gptkbp:bfsParent |
gptkb:Chiron_Corporation
|
| gptkbp:age |
9 months to 55 years
|
| gptkbp:approves |
gptkb:2005
gptkb:FDA |
| gptkbp:average_temperature |
2 to 8 degrees Celsius
|
| gptkbp:clinical_trial |
Phase 3
|
| gptkbp:contraindication |
severe allergic reaction to any component
|
| gptkbp:dosage_form |
gptkb:item
|
| https://www.w3.org/2000/01/rdf-schema#label |
Menactra
|
| gptkbp:is_vulnerable_to |
single dose
conjugate vaccine recommended for college students recommended for military recruits recommended for travelers to certain countries recommended for individuals with certain medical conditions recommended for close contacts of infected individuals |
| gptkbp:manager |
intramuscular
|
| gptkbp:manufacturer |
gptkb:Sanofi_Pasteur
|
| gptkbp:side_effect |
headache
fever injection site reactions |
| gptkbp:targets |
meningococcal disease
|